Wnt/β‐catenin signalling has been reported to be an essential pathway in mediating cardiac hypertrophy.24 In Angiotensin II‐treated cardiomyocytes, multiple Wnt ligands were induced to activate β‐catenin and stimulate the expressions of hypertrophic biomarkers, thereby leading to hypertrophy response.24 We reported that the Wnt/β‐catenin signalling was activated in cardiac hypertrophy. The gene discussed is AGT; the disease is cardiac hypertrophy.